Chemomab Therapeutics Ltd. (CMMB)
2.59
-0.10
(-3.72%)
USD |
NASDAQ |
Sep 10, 16:00
2.59
0.00 (0.00%)
After-Hours: 18:56
Chemomab Therapeutics Debt to Equity Ratio : 0.00 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.00 |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.00 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.0281 |
| December 31, 2024 | 0.0239 |
| September 30, 2024 | 0.021 |
| June 30, 2024 | 0.0361 |
| March 31, 2024 | 0.0293 |
| December 31, 2023 | 0.0231 |
| September 30, 2023 | 0.0061 |
| June 30, 2023 | 0.0064 |
| March 31, 2023 | 0.0063 |
| December 31, 2022 | 0.0059 |
| September 30, 2022 | 0.0055 |
| June 30, 2022 | 0.0054 |
| March 31, 2022 | 0.0056 |
| December 31, 2021 | 0.0056 |
| September 30, 2021 | 0.0055 |
| June 30, 2021 | 0.0058 |
| March 31, 2021 | 0.0072 |
| December 31, 2020 | 0.0545 |
| September 30, 2020 | 0.0441 |
| June 30, 2020 | 0.0338 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0294 |
| December 31, 2019 | 0.0749 |
| September 30, 2019 | 0.1612 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | -0.5123 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.00 |
| December 31, 2015 | 0.00 |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| BioLineRx Ltd. | 0.5767 |
| XTL Biopharmaceuticals Ltd. | -- |
| Kamada Ltd. | 0.0438 |
| Can-Fite BioPharma Ltd. | -- |
| Galmed Pharmaceuticals Ltd. | 0.0101 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 10.24M |
| Total Liabilities (Quarterly) | 1.553M |
| Shareholders Equity (Quarterly) | 8.685M |
| Current Ratio | 6.411 |
| Net Debt Paydown Yield | 0.50% |